Mitchell L. Krassan
2013
In 2013, Mitchell L. Krassan earned a total compensation of $225.1K as Executive Vice President and Chief Strategy Officer at TherapeuticsMD.
Compensation breakdown
| Non-Equity Incentive Plan | $16,711 |
|---|---|
| Salary | $200,000 |
| Other | $8,429 |
| Total | $225,140 |
Krassan received $200K in salary, accounting for 89% of the total pay in 2013.
Krassan also received $16.7K in non-equity incentive plan and $8.4K in other compensation.
Rankings
In 2013, Mitchell L. Krassan's compensation ranked 11,413th out of 12,286 executives tracked by ExecPay. In other words, Krassan earned more than 7.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,413 out of 12,286 | 7th |
Division Manufacturing | 4,283 out of 4,612 | 7th |
Major group Chemicals And Allied Products | 1,358 out of 1,462 | 7th |
Industry group Drugs | 1,081 out of 1,156 | 7th |
Industry Pharmaceutical Preparations | 838 out of 890 | 6th |
Source: SEC filing on April 28, 2016.
Krassan's colleagues
We found three more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2013.